BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Ribo and Boehringer Ingelheim Collaborate on Liver Disease Treatments

More than 440 million people worldwide are estimated to live with NASH, an inflammatory liver disease that is caused by accumulation of fat in the liver. O...

January 04, 2024 | News

Glenmark Launches First Biosimilar of Liraglutide, a Popular Anti-Diabetic Drug in India

‐ The anti‐diabetic biosimilar has been launched under the brand name Lirafit™, and is indicated for improving glycemic control in adult ...

January 03, 2024 | News

Health On Cloud Goes Global with Metaverse Medical Platform

This expansion is scheduled to launch in Kazakhstan, Colombia, and several other Latin American countries in 2024, marking a strategic move that ...

January 02, 2024 | News

LumiraDx to Sell Point of Care Technology to Roche

The administrators have signed a definitive agreement to sell certain companies of the LumiraDx group related to LumiraDx’s innovative point of care ...

January 02, 2024 | News

Recbio's REC610 Shingles Vaccine Shows Positive Interim Trial Results in the Philippines

Previously, the Company conducted a GSK Shingrix® active-controlled FIH clinical trial of REC610 in the Philippines. The Interim Analysis (IA) res...

December 29, 2023 | News

Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment

--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...

December 29, 2023 | News

HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions

Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...

December 29, 2023 | News

Innovent and SanegeneBio Collaborate on siRNA Drug for Hypertension Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 27, 2023 | News

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

The ISPRI toolkit is a secure web-based platform that allows researchers to rapidly assess the immunogenic risk of biologic candidates. The fu...

December 21, 2023 | News

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

December 18, 2023 | News

Ribo and Boehringer Ingelheim Collaborate on Liver Disease Treatments

Glenmark Launches First Biosimilar of Liraglutide, a Popular Anti-Diabetic Drug in India

Health On Cloud Goes Global with Metaverse Medical Platform

LumiraDx to Sell Point of Care Technology to Roche

Recbio's REC610 Shingles Vaccine Shows Positive Interim Trial Results in the Philippines

Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment

HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions

Innovent and SanegeneBio Collaborate on siRNA Drug for Hypertension Treatment

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

Takeda Gets Positive CHMP Opinion for HYQVIA® in CIDP Maintenance Therapy

Singapore Introduces New Treatment for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation

First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging

Zhongchao Inc. Partners with Public Health Foundation for Cancer Treatment Advancements

Stay Connected